Prognostic value of soluble ST2 and NT-proBNP in symptomatic patients with heart failure and reduced ejection fraction

10 May 2026 (15:30 - 16:15)

Organised by:

Abstract

Slides

Sign in for access options

About the speaker

Doctor Argyrios Ntalianis

Alexandra University Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail

Predictive accuracy of the H2FPEF score in patients with and without lung disease

Doctor C. Wegner Wippel (New Haven, US)

Abstract Slides

Presentation thumbnail

Predictors of heart failure with reduced or mildly reduced ejection fraction development in hypertrophic cardiomyopathy: a single-centre study

Doctor H. Santos Moreira (Porto, PT)

Abstract Slides

Presentation thumbnail

Six-minute walk distance uncovers high-risk HFrEF patients despite guideline-based assessment

Doctor M. Chudy (Bratislava, SK)

Abstract Slides

Presentation thumbnail

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Doctor H. Seo (Seoul, KR)

Abstract Slides

Presentation thumbnail

Determinants of recurrent-event model performance in TOPCAT-Americas

Doctor B. Szabo-Soderberg (Stockholm, SE)

Abstract Slides

Access the full session

Session thumbnail

Progress in predicting prognosis in heart failure?

The Event

Event poster

Heart Failure 2026

10 May 2026 15:30 CET

You may be interested in

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Congress Session

Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources